41st Annual Cardiovascular
Conference
At Snowmass
Program Director: Spencer B. King III,
MD, MACC
January
11 – 15, 2010
Snowmass Resort
Snowmass, Colorado
|
Learning Pathway: General Cardiology: Hypertension,
Lipids and Prevention |
Monday, January 11
7:30 a.m. What
Is the Most Accurate and Cost-effective Way to Non-invasively Evaluate
Patient’s Chest Pain in the Emergency Department?
Dr. Kramer
7:50 a.m. The
Timing of Angiography and Revascularization in Patients with Non-STEMI
ACS
Dr. King
8:10 a.m. Anti-thrombotic
Therapy in ACS
Dr. Williams
8:30 a.m. New
Recommendations from the ACS Guidelines
Dr. O’Gara
8:50 a.m.
– Case Presentations with Questions and Answers
9:30 a.m. Cases
- Dr. King
Cases
– Dr. Kramer
Cases
– Dr. O’Gara
3:30 p.m. Imaging
Coronary Calcium and CTA: How to Choose?
Dr. Kramer
3:50 p.m. CT
Angiography and Stress Imaging for CAD Detection and Prognostication
(Form and Function): Competitive or Complementary?
Dr. Beller
4:10 p.m. Secondary
Prevention and Optimal Medical Management
Dr. O’Gara
4:30 p.m. Revascularization
or Medical Therapy Only: Lessons from COURAGE and BARI 2D
Dr. King
4:50 p.m. PCI
vs. CABG: Lessons and Pitfalls from Randomized Trials and Registries
Dr. Williams
5:10 p.m. Minimally
Invasive and Hybrid Surgery
Dr. Lytle
5:30 p.m.
Case Presentations with Questions and Answers
Cases
- Dr. Beller
Cases
1 – Dr. Gersh
Cases
2 – Dr. Gersh
Cases
3 – Dr. Gersh
Cases
– Dr. Kramer
Cases
– Dr. O’Gara
Cases
– Dr. Williams
Tuesday, January 12
7:30 a.m. Decades
of Reperfusion, Yet Controversies Persist
Dr. Ross
7:50 a.m.
Primarily
PCI – Optimizing Outcomes (Culprit vs. Multivessel –
DES vs. BMS)
Dr. King
8:10 a.m. Current
Status of Cardioprotection
Dr. Holmes
8:30 a.m. The
Role of Ischemia in Sudden Cardiac Death: Implications for Revascularization
and the ICD
Dr. Gersh
8:50 a.m. Regenerative
Medicine
Dr. Forrester
9:10 a.m.
– Case Presentations with Questions and Answers
9:30 a.m.
Cases – Dr. Forrester
Cases
– Dr. Gersh
Cases
1 – Dr. Williams
Cases
2 – Dr. Williams
3:30 p.m. The
Epidemic of CHF
Dr. Yancy
3:40 p.m. Advances
in Non-invasive Imaging to Identify Etiology of New Onset CHF
Dr. Kramer
4:00 p.m. Comprehensive
Medical Therapy for CHF
Dr. Yancy
4:20 p.m. Optimizing
Outpatient Care Systems
Dr. Fowler
4:40 p.m. Therapies
for HCM
Dr. Nishimura
5:00 p.m. Surgical
Options for Advanced CHF
Dr. Lytle
5:20 p.m. New
Developments in BVAD and LVAD as Bridge to Transplant and Destination
Therapies
Dr. Fowler
5:40 p.m.
Case Presentations with Questions and Answers
Cases
– Dr. Fowler
Cases
– Dr. Kramer
Cases
– Dr. Nishimura
Cases
– Dr. Yancy
Wednesday, January 13
7:30 a.m. Rate
vs. Rhythm Control: The Role of New Atrial Anti-arrhythmic and Antithrombotic
Drugs
Dr. Winkle
7:50 a.m. Management
of Atrial Fibrillation in Patients with LV Dysfunction
Dr. Gersh
8:10 a.m. Current
Status of Catheter Ablation for Atrial Fibrillation and Flutter
Dr. Winkle
8:30 a.m. Surgical
and Hybrid Approaches to Refractory Atrial Arrhythmias
Dr. Wechsler
8:50 a.m.
– Case Presentations with Questions
and Answers
9:30 a.m. Cases
– Dr. Winkle
3:30 p.m. What’s
New in Pacing?
Dr. Conti
3:50 p.m. Risk
Stratification and the Role of Molecular Genetics
Dr. Forrester
4:10 p.m. Status
of Drug Therapy and Selection of ICD Candidates
Dr. Conti
4:30 p.m. The
Patient with ICD and Recurrent Shocks: Management Approaches Including
RF Ablation
Dr. Conti
4:50 p.m. Screening
Athletes for Arrhythmia Risk
Dr. R. Vogel
5:10 p.m. Public
Access Defibrillation: Is It Effective?
Dr. Winkle
5:30 p.m.
Case Presentations with Questions and Answers
Cases
– Dr. Conti
Cases
– Dr. Winkle
Thursday, January 14
7:30 a.m. Imaging
for Quantification and Selection of Therapy in Valvular Heart Disease
Dr. Nishimura
7:50 a.m. Mitral
Valve Repair
Dr. Wechsler
8:10 a.m. Aortic
Valve Implantation: Percutaneous and Surgical
Dr. Holmes
8:30 a.m. Surgical
Approach to Complicated Aortic Valve Disease
Dr. Wechsler
8:50 a.m.
– Case Presentations with Questions
and Answers
9:30 a.m.
Cases 1 – Dr. Nishimura
Cases
2 – Dr. Nishimura
Cases
3 – Dr. Nishimura
3:30 p.m. Screening
the General Population for CHD Risk
Dr. R. Vogel
3:50 p.m. Insulin-sensitizing
or Insulin-providing Initial Strategy: Are Thiazolidinediones Effective
in Atherosclerosis and Restenosis Therapy?
Dr. Wyne
4:10 p.m. Clinical
Value of Imaging to Detect Ischemia in Patients with Type II Diabetes
Dr. Beller
4:30 p.m. Glucose
Control in the ICU and CCU: Time for Reappraisal?
Dr. Wyne
4:50 p.m. Raising
HDL: Is the Tide Rising?
Dr. Forrester
5:10 p.m. What
Is the Role for Genomic Testing in CAD Patients?
Dr. King
5:30 p.m.
Case Presentations with Questions and Answers
Cases
– Dr. Forrester
Cases
– Dr. Holmes
Cases
– Dr. Vogel
Cases
– Dr. Wyne
Friday, January 15
7:30 a.m. Carotid
Stenting: Optimal Selection of Candidates and Outcomes
Dr. Holmes
7:50 a.m. Interventions
in PVD
Dr. Mahmud
8:10 a.m. ASD
and PFO
Dr. Williams
8:30 a.m. Common
Problems of the Survivors of Surgery for Congenital Heart Disease
Dr. Warnes
8:50 a.m.
– Case Presentations with Questions
and Answers
9:30 a.m.
Cases – Dr. Mahmud
Cases
1 – Dr. Warnes
Cases
2 – Dr. Warnes
Cases
3 – Dr. Warnes
Cases
– Dr. Williams
3:30 p.m.
Special
Lecture “End of Life”
Dr. R. Vogel
3:50 p.m. Initial
Evaluation and Therapy of Hypertension
Dr. Warnes
4:10 p.m. Management
of Hypertension in Patients with CHF
Dr. Fowler
4:30 p.m. Renal
Stenting: When It Should Be Considered
Dr. Mahmud
4:50 p.m. Advances
in Treatment of Sleep Disorders
Dr. Nishimura
5:10 p.m. Heart
Disease in Pregnancy
Dr. Warnes
5:30 p.m.
Case Presentations with Questions and Answers
Cases
– Dr. Mahmud
Cases
1 – Dr. Warnes
Cases
2 – Dr. Warnes
Cases
3 – Dr. Warnes
| 
